Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
Jacqueline A FrenchSteve S ChungGregory L KraussSang Kun LeeMaciej MaciejowskiWilliam E RosenfeldMickael R SperlingMarc KaminPublished in: Epilepsia (2021)
Long-term retention in the C013 OLE study demonstrated sustained safety and tolerability of adjunctive cenobamate treatment up to 7.8 years in adults with treatment-resistant focal seizures taking one to three ASMs.